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tion, and the occasional complications of breast aspiration in
particular, are discussed in detail.
As might be expected in a multi-author book there is some
variation in the quality, and some overlap in content of the
contributions. It is a pity that the layout of text and photo-
graphs in a major section, on instruments and techniques, is
disjointed, making reading uncomfortable. Many of the
detailed photographs, although not difficult to understand,
have no legends, and are separated from the relevant text.
I agree with Professor David L. Page in his foreword that
'the value of this slim, multi-author volume lies in the wealth
of clinical experience presented.'
Anyone faced with having to start using fine needle aspira-
tion of the breast in clinical practice, and more especially
with being the aspirator, should find this book helpful.
J. Lamb
Xenobiotics and Cancer. Implications for Chemical Car-
cinogenesis and Cancer Chemotherapy
Edited by L. Ernster, H. Esumi, Y. Fujii, H.V. Gelboin, R.
Kato & T. Sugimura, Tokyo/London: Japan Scientific Press/
Taylor & Francis Ltd, 1991, 368 pp. £85.00.
This volume describes the Proceedings of the 21st Interna-
tional Symposium of the Princess Takamatsu Cancer
Research Fund, which was held in Tokyo, 1990. This Sym-
posium was largely concerned with the metabolic activation
of chemical carcinogens and anti-cancer drugs, with the
defense mechanisms against their action, and with the
biomonitoring methods available for detecting exposure to
those compounds. Publications of conference proceedings are
often rather dreary volumes, consisting of highly specialised
chapters, bearing little relation to each other. This book in
contrast provides an excellent survey of current biochemical
thinking on chemical, molecular biological and phar-
macological aspects of carcinogenesis. The authors are world
experts in their respective fields and the topics for the
chapters have in general been logically thought out. The
result is an impressive, almost text-book like, discussion of
chemical carcinogenesis, which will be of value to all post-
graduates and research workers in this field.
The book is divided into six sections and carries 30
chapters, each by different authors. The first section comp-
rises reports of two keynote lectures, the first covering
cytochrome P450 distribution and function (Gelboin et al.)
and the second covering the importance of the balance
between active oxygen species and antioxidants in the car-
cinogenesis process (Ernster). The cytochrome P450 multi-
enzyme family is the primary factor responsible for the
activation and detoxification of xenobiotics and the utility of
monoclonal antibodies and cDNA expression for the mapp-
ing of P450 distribution and function was concisely sum-
marised by Gelboin. The concept was presented by Ernster
that chemical carcinogenesis and its prevention may have as
a common denominator the metabolic activation of a
xenobiotic, which may result in the production of active
oxygen (which is involved in the initiation, promotion and
progression stages of carcinogenesis) or of antioxidant
mechanisms which can scavage these radicals and prevent
their harmful effects.
Metabolic activation of xenobiotics was further considered
in Section 2. Much evidence was (rightly) placed on the role
of cytochrome P450s, the topics discussed being the influence
of the anticarcinogen dehydroepiandrosterone on P450, the
pharmacogenetics and polymorphism of P450's, and the
aromatase cytochrome P450 complex. The possible contribu-
tion of (non-cytochrome P450 dependent) oxygen radicals to
bioactivation of carcinogens is a further important
parameter, which was discussed using benzo(a)pyrene as an
example. Other bioactivation processes that were reviewed
were those involving glutathione conjugate formation (e.g.
1,2-dihaloalkanes), acetyltransferase and sulphontransferase
(aromatic amines). Surprisingly, epoxide hydrolase, which is
involved in epoxide detoxification and which is polymor-
phically expressed, was not given much coverage, although
the importance of the N-acetylation phenotype to the car-
cinogenic effect of arylamines was included.
Section 3, which partially overlaps with Section 2, is about
gene regulation ofxenobiotic metabolising enzymes. In a field
moving as fast as this there are naturally some areas which
have progressed since the reviews were written and one can
find omissions such as y-glutamyl transpeptidase. However
other areas which are well reported are the regulation of
cytochrome P-450, the elegant studies on the nuclear
glucocorticoid receptor, regulation of DT-diaphorase, and
expression of glutathione transferases. The important effects
of xenobiotics on signal transduction and Ca2+ concentra-
tions, (although not particularly appropriate to the section
title), are also discussed.
Resistance processes to cancer drugs from the basis of
Section 4. Resistance to many drugs is associated with the
expression of a 170 kD glycoprotein (P-glycoprotein), whose
function is clearly reviewed. Exciting prospects exist for anti-
cancer agents which could block the transport activity of
P-glycoprotein. Other enzymes involved in resistance which
are discussed are glutathione transferases (GST), glyoxalase I
and UDP-glucuronosyl transferases. The first of these
enzymes appears under different roles in each of Sections 2, 3
and 4. Although it might have been a challenging task for a
contributor, an overall summary with a unifying hypothesis
on function, polymorphism etc. of GST might have been
interesting to include.
The next shorter section covers xenobiotics as a cause of
human cancer. Three papers cannot even scratch the surface
of this subject, and indeed only one class of compounds (the
hetrocyclic amines) are considered in detail. (It however
maybe appropriate to choose these as the sole example in this
volume, in view of the pioneering work carried out by the
Japanese on hetrocyclic amines in cooked food.) To make up
for the deficiency in covering other compounds there is a
penetrating and though-provoking review by Ames et al.
pointing out the importance of concentrating our attention
on natural chemicals, in addition to the synthetic chemicals
which have previously occupied many regulators' minds.
One real possibility for determining which xenobiotics are
involved in human cancer initiation rests in the novel discip-
lines of 'biomonitoring', reviewed in Section 6. These techni-
ques allow the detection of carcinogen adducts with DNA at
levels down to ca. 1 modified DNA base per cell. Screening
systems to monitor qualitatively and quantitatively exposures
to mixtures of carcinogens are being developed using
measurements of both DNA and protein (especially haemo-
globin) adducts. Four papers review the major techniques
employed (32P-postlabelling, immunoassays, gas chromato-
graphy/mass spectrometry) for DNA and protein adduct
measurements, and the relation of these data with mutations
and chromosomal changes is discussed. This is a most inter-
esting section of the book, and an appropriate one for its
conclusion. Again because of the pace ofprogress in this area
we know now of interesting novel findings, for example
relating to mutation of the p53 gene, which could not have
been included at the time of writing. This sadly is
unavoidable in a publication now of a meeting held 18
months ago.
The book is notable for its high quality of editing and
would certainly be a valuable addition to the bookshelves of
chemical or biological carcinogenicists. The range of topics
reviewed, although not comprehensive, is wide and the book
is a useful source of up to date knowledge on molecular
findings in chemical carcinogenesis.
P. Farmer